KPC Pharmaceuticals, Inc. (600422.SS) SHH

13.12

-0.01(-0.08%)

Updated at December 05 11:29AM

Currency In CNY

Valuation

Market Cap11.94B
Enterprise Value10.43B
P/E Ratio18.75
PEG Ratio-1.38
Price/Sales Ratio1.29
Price/Book Ratio1.87
Enterprise/Revenue1.42
Enterprise/EBITDA13.93

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.07
Operating Margin0.09

Management Effectiveness

Return On Assets0.04
Return On Equity0.1

Income Statement

Revenue8.4B
Revenue/Share10.17
Gross Profit3.63B
EBITDA964.84M
Net Income648.08M
Diluted EPS0.86

Balance Sheet

Total Cash2.76B
Total Cash/Share3.65
Total Debt1.82B
Total Debt/Equity0.34
Current Ratio1.93
Book Value Per Share9.06

Price History

52-Week Change-13.9
52-Week High18.64
52-Week Low13.07
Moving Average 50 Days13.74
Moving Average 200 Days15.12

Statistics

Average Volume7.89M
Shares Outstanding756.98M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield2.28
Payout Ratio0.05
Last Split Factor2:1
Last Split DateMay 09, 2016